Amae Health Secures $15M Series A to Scale Precision Mental Health Care for Serious Mental Illness

Date:

Share post:

Los Angeles-based Amae Health has announced the close of a $15 million Series A funding round, a major milestone in its mission to transform how care is delivered to individuals with serious mental illness (SMI). Founded in 2022, the startup aims to unify the fragmented care system by delivering fully integrated behavioral, physical, and supportive services—laying the groundwork for precision mental health care for serious mental illness across the country.

At a time when venture capital in behavioral health has slowed significantly, Amae Health’s ability to raise capital signals strong investor confidence in a model built to solve one of healthcare’s most difficult and overlooked challenges.

Transforming a Broken System

For decades, individuals with SMI have received care through disconnected and episodic systems—ranging from hospital psych units and primary care clinics to community mental health providers and emergency departments. This lack of continuity often leads to poor outcomes, high readmission rates, and unnecessary suffering.

Amae Health’s answer is a comprehensive, team-based approach inspired by the U.S. Department of Veterans Affairs’ mental health intensive case management program. Their model combines psychiatrists, social workers, peer support specialists, primary care physicians, and health coaches into a single, coordinated care system.

“Our mission at Amae Health is to provide lifelong, adaptive care that addresses both the immediate and long-term needs of our patients,” said Sonia Priscilla García, co-founder and Chief Product Officer, on LinkedIn. “This new funding will be instrumental in scaling our operations and enhancing our data-driven precision medicine platform.”

This integrated model is central to delivering precision mental health care for serious mental illness, a field long in need of innovative, patient-centered reform.

Geographic Expansion and Clinical Growth

With the Series A funds, Amae Health will expand into four new markets: North Carolina, Texas, New York, and Ohio. These states represent critical opportunities to implement comprehensive behavioral health models in regions with existing service gaps.

The company’s expansion will focus on deploying community-based, tech-enabled clinics that embody precision mental health care for serious mental illness. Each site will deliver wraparound services tailored to meet the unique needs of patients who often face a mix of psychiatric, physical, and social challenges.

Amae’s scalable approach is designed to ensure consistency and quality—making it possible to replicate outcomes across diverse populations and geographies.

Building the Future of Psychiatry With Palantir

To supercharge its clinical precision, Amae Health is partnering with Palantir Technologies Inc. (NYSE: PLTR) to co-develop a cutting-edge precision medicine platform for psychiatry. This platform will use real-time data analytics and predictive modeling to personalize treatment plans, reduce trial-and-error in prescribing, and proactively identify emerging health risks.

This is a core pillar of the company’s commitment to precision mental health care for serious mental illness—leveraging technology not just for operational efficiency, but for smarter, more responsive clinical decisions.

Amae Health is also collaborating with UCLA and Apple Inc. (Nasdaq: AAPL) on a new research initiative that explores how digital sensing can improve mental health outcomes. This includes using wearable devices and smartphone data to monitor patient behavior and detect early signs of decompensation—providing a safety net for those who need it most.

Strong Investor Confidence in a Challenging Market

In today’s cautious venture capital environment, behavioral health startups must demonstrate real differentiation to secure funding. Amae Health’s $15 million Series A was led by Quiet Capital and included new investments from Healthier Capital, Baszucki Group, and Mike Volpi of Index Ventures. Previous investors from the seed round—Bling Capital, Virtue, 8VC, and Able Partners—also returned, a testament to the company’s momentum and leadership.

Investors see Amae Health not just as a healthcare company, but as a system redesign in motion—delivering a scalable solution for precision mental health care for serious mental illness at a time when most of the industry is still stuck in reactive, fee-for-service models.

Value-Based Care That Centers on Outcomes

Amae Health is also leading a shift from fee-for-service reimbursement to value-based contracts with payers. In this model, care teams are incentivized to achieve lasting improvements in patient outcomes—rather than simply billing for volume.

At the 2023 BHB VALUE conference, García pointed to the pitfalls of traditional payment systems: “Care that is driven by financial reimbursement is not designed to solve a problem; it’s designed to continue the cycle of reimbursement.”

Through value-based contracts, Amae Health can deliver precision mental health care for serious mental illness that goes beyond psychiatric symptom management to include housing support, nutrition assistance, medication adherence, and community reintegration.

Addressing the Full Picture of Mental Illness

What sets Amae Health apart is its recognition that SMI is not just a psychiatric issue—it’s a whole-person health issue. Patients with SMI are more likely to experience chronic physical health problems, social isolation, and poverty. These factors can’t be resolved through therapy alone.

By aligning clinical services with social determinants of health and a long-term treatment philosophy, Amae is building a care model that reflects the reality of patient needs. In doing so, it is setting a new standard for precision mental health care for serious mental illness, where patients receive support not just to survive—but to thrive.

A Model Built for the Future of Behavioral Health

While the overall behavioral health funding landscape has tightened since the boom of 2021, Amae Health’s successful Series A shows that well-designed, outcome-driven models can still attract capital. Other companies like Pelago ($58M), Two Chairs ($72M), and Grow Therapy ($88M) are part of a new wave of investments focused on real clinical value.

Amae’s differentiator is its bold, systemic vision—one that reimagines care delivery for the most vulnerable populations and builds durable infrastructure around it.

With robust funding, strategic partnerships, and a mission-driven team, Amae Health is poised to lead the next generation of precision mental health care for serious mental illness—bringing scalable, compassionate, and tech-enabled solutions to the people who need them most.

spot_img

Related articles

Talkspace Partners with Evernow to Elevate Menopause Mental Health Support for Women

In recent years, the importance of mental health has gained significant attention, and now more companies are recognizing...

The Growing Rural Opioid Crisis: Challenges and Opportunities for Treatment

Opioid addiction has become a significant issue in the United States, with the rural opioid crisis hitting communities...

The Alarming Rise in Alcohol-Related Deaths: A Focus on Women and the Continued Need for Action

In a revealing new study by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a troubling trend...

LifeStance Health Under Fire: Former Employees Claim Payment Arrangements Violate Labor Laws

LifeStance Health Group, a prominent player in the outpatient mental health space, is facing legal challenges from former...